We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $157M Turnover 30.95%
1-Year Est. Return 60.08%
This Fund
S&P 500
This Quarter Est. Return
+14.7%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
–
AUM
$120M
AUM Growth
+$10.1M
Cap. Flow
+$929K
Cap. Flow %
0.77%
Top 10 Hldgs %
40.6%
Holding
79
New
12
Increased
19
Reduced
13
Closed
14
Avg Time Held
2.1 years
Top 10 Avg Time Held
2.2 years
Top 20 Avg Time Held
1.9 years

Top Sells

Rank Stock Value
1
WBD icon
Warner Bros
WBD
+$2.87M
2
BRKL icon
Brookline Bancorp
BRKL
+$1.9M
3
TGB
Trekor Metals
TGB
+$1.53M
4
CLPT icon
ClearPoint Neuro
CLPT
+$1.41M
5
NMRK icon
Newmark Group
NMRK
+$1.38M

Sector Composition

Rank Sector Weight
1 Healthcare 35.2%
2 Industrials 11.34%
3 Materials 10.84%
4 Consumer Staples 9.52%
5 Technology 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
HRI icon
51
Herc Holdings
HRI
$4.15B
$875K 0.73%
+7,500
New +$968K
2025 Q3
0 quarters
SVC
52
Service Properties Trust
SVC
$803M
$813K 0.68%
60,000
-20,000
-25% -$271K
2021 Q3
16 quarters
OSTX icon
53
OS Therapies Inc
OSTX
$65.5M
$784K 0.65%
400,000
+25,000
+7% +$49.5K
2024 Q3
4 quarters
ASRT icon
54
DELISTED
Assertio
ASRT
$638K 0.53%
48,292
– –
2023 Q2
9 quarters
NVNO icon
55
enVVeno Medical
NVNO
$5.44M
$544K 0.45%
+17,143
New +$1.75M
2025 Q3
0 quarters
CRIS icon
56
Curis
CRIS
$1.25M
$540K 0.45%
16,250
+5,250
+48% +$182K
2022 Q4
11 quarters
CMPX icon
57
Compass Therapeutics
CMPX
$161M
$525K 0.44%
+150,000
New +$474K
2025 Q3
0 quarters
NWL icon
58
Newell Brands
NWL
$2.46B
$524K 0.44%
100,000
– –
2025 Q1
2 quarters
PCAR icon
59
PACCAR
PCAR
$58.3B
$492K 0.41%
5,000
– –
2025 Q2
1 quarter
LYB icon
60
LyondellBasell Industries
LYB
$20.2B
$490K 0.41%
+10,000
New +$564K
2025 Q3
0 quarters
ASH icon
61
Ashland
ASH
$3.28B
$479K 0.4%
+10,000
New +$526K
2025 Q3
0 quarters
AVNW icon
62
Aviat Networks
AVNW
$250M
$459K 0.38%
20,000
– –
2025 Q2
1 quarter
HELE icon
63
Helen of Troy
HELE
$690M
$378K 0.32%
15,000
+5,000
+50% +$121K
2025 Q2
1 quarter
BCDA icon
64
BioCardia
BCDA
$14.7M
$168K 0.14%
130,000
– –
2024 Q4
3 quarters
ELTX icon
65
Elicio Therapeutics
ELTX
$48.5M
$65.6K 0.05%
6,000
-19,000
-76% -$192K
2021 Q1
18 quarters
APA icon
66
APA Corp
APA
$16.5B
– –
-50,000
Closed -$915K –
BILL icon
67
BILL Holdings
BILL
$4B
– –
-10,000
Closed -$463K –
BRKL icon
68
DELISTED
Brookline Bancorp
BRKL
– –
-180,000
Closed -$1.9M –
CGTX icon
69
Cognition Therapeutics
CGTX
$69.5M
– –
-250,000
Closed -$77.5K –
COHU icon
70
Cohu
COHU
$2.6B
– –
-20,000
Closed -$385K –
EG icon
71
Everest Group
EG
$14.6B
– –
-2,000
Closed -$680K –
FEMY icon
72
Femasys
FEMY
$14.5M
– –
-11,250
Closed -$217K –
FSLR icon
73
First Solar
FSLR
$19.2B
– –
-5,000
Closed -$828K –
B icon
74
Barrick Mining
B
$66.8B
– –
-25,000
Closed -$521K –
NKTR icon
75
Nektar Therapeutics
NKTR
$1.29B
– –
-45,000
Closed -$1.16M –

Similar funds

CM Management's Q3 2025 Portfolio in Review

As of Q3 2025, CM Management held 79 positions worth $120M, up 9.2% from $110M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

CM Management's Q3 2025 filing shows 12 new, 19 increased, 13 reduced and 14 closed positions. Its largest new stake was Keurig Dr Pepper: 80,000 shares worth $2.04M. The largest sale was Warner Bros, an estimated $2.87M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 31% a quarter earlier, followed by Industrials and Materials.

  • CM Management's largest Q3 2025 buy was Keurig Dr Pepper: 80,000 shares worth $2.04M.
  • CM Management added most to Euronet Worldwide in Q3 2025, an estimated $1.1M increase.
  • CM Management's biggest Q3 2025 reduction was Trekor Metals, cutting an estimated $1.53M.
  • CM Management fully exited Warner Bros in Q3 2025, selling an estimated $2.87M.
  • CM Management's ten largest holdings make up 41% of its $120M portfolio in Q3 2025.
  • CM Management opened 12 new positions and closed 14 in Q3 2025.
  • CM Management's portfolio value rose 9.2% quarter-over-quarter to $120M.

Based on CM Management's 13F filing for Q3 2025, filed 13 Nov 2025.